Bedognetti, Davide <br/><br/>
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era.  [electronic resource] 

 -  International journal of hematology  Mar 2010 
 - 342-4; author reply 345-6 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>1865-3774 
<br/><br/><label>Standard No.: </label>10.1007/s12185-010-0522-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--adverse effects<br/>Female<br/>Hepatitis B--diagnosis<br/>Hepatitis B Antibodies--blood<br/>Hepatitis B Core Antigens--immunology<br/>Humans<br/>Immunocompromised Host<br/>Lymphoma--complications<br/>Male<br/>Middle Aged<br/>Rituximab<br/>Seroepidemiologic Studies